Scott Terrillion
Sec'y; Chief Compliance & G.C., Tvardi Therapeutics, Inc.
Companies
- Tvardi Therapeutics, Inc.Sec'y; Chief Compliance & G.C. May 11, 2017 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Tvardi Therapeutics, Inc. TVRD7,190 shares2$7.1K at $0.99Feb 28, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 28, 2025Sold 163 shares at $4.76 of Tvardi Therapeutics, Inc.2
- Apr 5, 2024Sold 2,753 shares at $0.83 of Tvardi Therapeutics, Inc.3
- Feb 29, 2024Sold 3,293 shares at $0.89 of Tvardi Therapeutics, Inc.4
- Feb 1, 2024Granted 13,500 shares of Tvardi Therapeutics, Inc.5
- Jun 23, 2023Sold 2,483 shares at $3.51 of Tvardi Therapeutics, Inc.6
- Apr 4, 2023Sold 2,481 shares at $4.91 of Tvardi Therapeutics, Inc.7
- Mar 3, 2023Sold 6,256 shares at $9.71 of Tvardi Therapeutics, Inc.8
- Feb 8, 2023Sold 7,770 shares at $0.53 of Tvardi Therapeutics, Inc.9
- Dec 21, 2022Sold 2,561 shares at $11.27 of Tvardi Therapeutics, Inc.10
- Apr 1, 2022Sold 1,642 shares at $11.91 of Tvardi Therapeutics, Inc.11
- Mar 3, 2022Sold 1,787 shares at $11.38 of Tvardi Therapeutics, Inc.12
- Feb 28, 2022Granted 5,333 shares of Tvardi Therapeutics, Inc.13
- Feb 25, 2022Sold 1,972 shares at $10.29 of Tvardi Therapeutics, Inc.13
- Feb 25, 2022Granted 20,000 shares of Tvardi Therapeutics, Inc.13
- Dec 17, 2021Granted 11,495 shares of Tvardi Therapeutics, Inc.14
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Apr 9, 2024
- 4SEC EDGARForm 4 filed Mar 4, 2024
- 5SEC EDGARForm 4 filed Feb 5, 2024
- 6SEC EDGARForm 4 filed Jun 27, 2023
- 7SEC EDGARForm 4 filed Apr 6, 2023
- 8SEC EDGARForm 4 filed Mar 7, 2023
- 9SEC EDGARForm 4 filed Feb 12, 2024
- 10SEC EDGARForm 4 filed Dec 23, 2022
- 11SEC EDGARForm 4 filed Apr 5, 2022
- 12SEC EDGARForm 4 filed Mar 4, 2022
- 13SEC EDGARForm 4 filed Mar 1, 2022
- 14SEC EDGARForm 4 filed Dec 21, 2021